论文部分内容阅读
Professor Da-Tong Chu is Chief Scientist of Medical Oncology and Chairman of Ethical Committee, Cancer Institute and Hospital, Chinese Academy of Medical Sci-ences(CAMS), Beijing. He is President of Chinese Society of Clinical Oncology (CSCO), Vice-Chairman of the GCP Center of National Anti-Cancer Drugs, and is the member of the Expert Committee of State Food and Drug Admin-istration(SFDA), and member of Chinese Pharmacopoeia Committee. After graduating from the Capital University of Medical Sciences and Union Medical College, he pursued his postgraduate study on the regulation of immunoglobu-lin secretion in malignant lymphoma. By modifying the
Professor Da-Tong Chu is Chief Scientist of Medical Oncology and Chairman of Ethical Committee, Cancer Institute and Hospital, Chinese Academy of Medical Sci-ences (CAMS), Beijing. He is President of Chinese Society of Clinical Oncology (CSCO), Vice- Chairman of the GCP Center of National Anti-Cancer Drugs, and is the member of the Expert Committee of State Food and Drug Admin-istration (SFDA), and member of Chinese Pharmacopoeia Committee. After graduating from the Capital University of Medical Sciences and Union Medical College, he pursued his postgraduate study on the regulation of immunoglobu-lin secretion in malignant lymphoma. By modifying the